• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Eli Lilly and Gilead’s combination cuts COVID-19 recovery time

cafead

Administrator
Staff member
  • cafead   Oct 09, 2020 at 11:02: AM
via Eli Lilly’s Olumiant (baricitinib) has a significant effect on recovery from COVID-19 when combined with Gilead Veklury (remdesivir), according to a large trial backed by funding from the US government.

article source
 

<